Bone Biologics Corporation (BBLGW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Bone Biologics Corporatio...

    NASDAQ: BBLGW · Real-Time Price · USD
    8.00
    -2.79 (-25.86%)
    At close: Sep 22, 2025, 9:36 AM

    Bone Biologics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -4.22M -9.43M -3.67M -1.1M
    Interest Income
    		 55.66K 1.87K 731.71 805.11
    Pretax Income
    		 -4.11M -8.95M -1.49M -1.61M
    Net Income
    		 -4.11M -8.95M -1.49M -1.61M
    Selling & General & Admin
    		 2.09M 2.52M 2.09M 1.02M
    Research & Development
    		 2.13M 6.91M 1.58M 82.04K
    Other Expenses
    		 n/a n/a n/a -44
    Operating Expenses
    		 4.22M 9.43M 3.67M 1.1M
    Interest Expense
    		 n/a n/a 731.71K 805.11K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 4.22M 9.43M 3.67M 1.1M
    Income Tax Expense
    		 n/a n/a n/a 1.6K
    Shares Outstanding (Basic)
    		 1.52M 263.14K 47.6K 43K
    Shares Outstanding (Diluted)
    		 1.52M 263.14K 47.66K 43.13K
    EPS (Basic)
    		 -4.83 -34.01 -31.15 -37.35
    EPS (Diluted)
    		 -4.83 -34.01 -31.2 -37.35
    EBITDA
    		 -4.11M 479.57K -4.4M -1.1M
    EBIT
    		 -4.11M -8.95M -3.67M -805.58K
    Depreciation & Amortization
    		 4.22M 9.43M 3.67M 1.1M

    Add to Watchlist